Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Corcel Exploration: Advancing a District-scale, Past-producing Copper-Gold Asset in Arizona November 3, 2025 CleanTech Lithium November 3, 2025 Locksley Resources LimitedReceives up to US$191M Potential Support from EXIM Bank November 3, 2025
Corcel Exploration: Advancing a District-scale, Past-producing Copper-Gold Asset in Arizona November 3, 2025